National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia

被引：10
|
作者：
Purohit, Vishnudutt [1 ]
Rapaka, Rao [1 ]
Frankenheim, Jerry [1 ]
Avila, Albert [1 ]
Sorensen, Roger [1 ]
Rutter, Joni [1 ]
机构：
[1] NIDA, Chem & Physiol Syst Res Branch, Div Basic Neurosci & Behav Res, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF NEUROVIROLOGY | 2013年 / 19卷 / 02期
关键词：
HIV; HAND; HAD; Dopamine; Drugs of abuse; IMMUNODEFICIENCY-VIRUS TYPE-1; DIFFERENT REGIONS; DENDRITIC CELLS; BRAIN; TRANSPORTERS; EXPRESSION; INFECTION; DEATH;
D O I：
10.1007/s13365-013-0153-2
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The National Institute on Drug Abuse organized a symposium on drugs of abuse, dopamine, and HIV-associated neurocognitive disorders (HAND)/HIV-associated dementia (HAD) in Rockville, Maryland, October4, 2011. The purpose of this symposium was to evaluate the potential role of dopamine in the potentiation of HAND/HAD by drugs of abuse. A summary of the symposium has been presented in this report.
引用
收藏
页码：119 / 122
页数：4
相关论文
共 50 条
  • [31] Determinants of Risk-Taking in HIV-Associated Neurocognitive Disorders
    Gomez, Daniela
    Power, Christopher
    Gill, M. John
    Fujiwara, Esther
    NEUROPSYCHOLOGY, 2017, 31 (07) : 798 - 810
  • [32] The role of tau protein in HIV-associated neurocognitive disorders
    Lecia AM Brown
    James Scarola
    Adam J Smith
    Paul R Sanberg
    Jun Tan
    Brian Giunta
    Molecular Neurodegeneration, 9
  • [33] Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders
    Irollo, Elena
    Luchetta, Jared
    Ho, Chunta
    Nash, Bradley
    Meucci, Olimpia
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (09) : 4283 - 4303
  • [34] Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale
    Cross, Sara
    Oenen, Nur
    Gase, Amber
    Overton, Edgar Turner
    Ances, Beau M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (05) : 1114 - 1122
  • [35] Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale
    Sara Cross
    Nur Önen
    Amber Gase
    Edgar Turner Overton
    Beau M. Ances
    Journal of Neuroimmune Pharmacology, 2013, 8 : 1114 - 1122
  • [36] Current understanding of HIV-associated neurocognitive disorders pathogenesis
    Gannon, Patrick
    Khan, Muhammad Z.
    Kolson, Dennis L.
    CURRENT OPINION IN NEUROLOGY, 2011, 24 (03) : 275 - 283
  • [37] The role of tau protein in HIV-associated neurocognitive disorders
    Brown, Lecia A. M.
    Scarola, James
    Smith, Adam J.
    Sanberg, Paul R.
    Tan, Jun
    Giunta, Brian
    MOLECULAR NEURODEGENERATION, 2014, 9 : 40
  • [38] The HAND Database: a gateway to understanding the role of HIV in HIV-associated neurocognitive disorders
    Griffin, Tess Z.
    Kang, Weiliang
    Ma, Yongjie
    Zhang, Ming
    BMC MEDICAL GENOMICS, 2015, 8
  • [39] Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-Associated Neurocognitive Disorders in the CHARTER Cohort
    Sakamoto, Maiko
    Marcotte, Thomas D.
    Umlauf, Anya
    Franklin, Donald, Jr.
    Heaton, Robert K.
    Ellis, Ronald J.
    Letendre, Scott
    Alexander, Terry
    McCutchan, J. A.
    Morgan, Erin E.
    Woods, Steven P.
    Collier, Ann C.
    Marra, Christina M.
    Clifford, David B.
    Gelman, Benjamin B.
    McArthur, Justin C.
    Morgello, Susan
    Simpson, David
    Grant, Igor
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 (01) : 36 - 42
  • [40] Aging with HIV and HIV-associated neurocognitive impairment
    Bennett, Teresa
    Walmsley, Sharon
    Bendayan, Reina
    AIDS, 2025, 39 (03) : 215 - 228
12345